From her GLP-1 weight loss journey to her new partnership with Ro, Serena Williams has sparked months of debate. Here's why her transformation remains so controversial.

Blockbuster weight-loss drugs are being linked to a rare but upsetting side effect that’s showing up in the shower drain. As ...

GLP-1 medications may be new, but the belief that smaller bodies hold the answer is not. What can two centuries of ...

Novo Nordisk filed a lawsuit against Eli Lilly that alleges advertising falsely claims Wegovy is weaker than it is.

The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more ...

Novo Nordisk sues Eli Lilly over GLP-1 weight-loss drug ads comparing Zepbound vs Wegovy doses; see what’s alleged, why it ...

Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective ...

Novo Nordisk has accused Eli Lilly of running ad campaigns containing “deliberately false” messages that mislead the public ...

Novo Nordisk sued rival drugmaker Eli Lilly, alleging false advertising claims about relative weight-loss drug performance.

In today’s healthcare landscape, people are looking for experiences that feel human, supportive and connected. Patients, caregivers and consumers are looking for brands they can relate to and trust.

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Add AP News on Google Add AP News as your ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Then Serena Williams returned to professional tennis by competing in ...